1 / 20

Chapter 4 Cultural, Legal, & Ethical Considerations

Chapter 4 Cultural, Legal, & Ethical Considerations. Controlled Substance Act - 1970. Schedule I – Only w/ approved protocol Heroin, marijuana Schedule II – Written rx only, no refills Codeine, morphine, methadone, oxycontin , ritalin , dilaudid

erica
Download Presentation

Chapter 4 Cultural, Legal, & Ethical Considerations

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Chapter 4Cultural, Legal, & Ethical Considerations

  2. Controlled Substance Act - 1970 • Schedule I – Only w/ approved protocol • Heroin, marijuana • Schedule II – Written rx only, no refills • Codeine, morphine, methadone, oxycontin, ritalin, dilaudid • Schedule III – Written rx or oral rx, 5 refills in 6 month period, container must have warning * Tylenol w/ codeine, testosterone • Schedule IV – Written or oral rx, 5 refills • Benzodiazepines (valium, xanax); Ambien • Schedule V – Written rx or OTC • Cough/cold meds (Robitussin AC); Lomotil

  3. Pharmacology – Drug Development • 1. Preclinical testing • 3 ½ years • Lab & animal research (rats) • Drug evaluated for safety • 2. Investigational New Drug Application • Drug company files IND with FDA • Must be approved or disapproved by FDA within 30 days • 3. Clinical Trials • Phase I • 1 year, 20-80 healthy volunteers (no disease) • Study of a drug’s safety profile & safe dosage • Studies Pharmacokinetics (absorption, distrib, metab, excretion)

  4. Pharmacology – Drug Development • Phase II • Controlled studies of 100-300 volunteers (people with disease) • To assess drug effectiveness and safe dosage, 2 years • Phase III • 3 years • Involves 1000-3000 patients in clinics & hospitals • Use of placebo • Physicians closely monitor all patients to determine safety, efficacy, and adverse reactions

  5. Pharmacology – Drug Development • Phase IV • 2 years, post-release of drug • To further assess therapeutic & adverse effects • Black Box Warning: placed on drug by FDA if severe reactions are occurring • ie: Advair, Accutane

  6. Pharmacology –Drug Development • 4. New drug application • Follows completions of all 3 clinical trials • Report of all scientific data (100 pages) • FDA has 6 months to review and approve • Final approval: New drug available to physicians to prescribe • Drug company must submit periodic reports to FDA • $12 billion in drug research and development per year, rising

  7. Cultural Practices • Native American • Harmony w/ nature, evil spirits cause disease • Asian • Traditional medicine, herbal remedies • African • Folk medicine, “healers” • Western • Prevention of disease, education, medications • Hispanic • Health = good luck, Illness = bad luck, bad deed • Heat and cold remedies instead of medicines

  8. Medication Preparation for Clinical • HEPARIN • Classification: Anticoagulant, Antithrombotic • Action: Prevents conversion of prothrombin to thrombin, prevents thrombus formation • Indications: To prevent & treat thromboembolism and PE; also used to maintain IV catheter patency (in low doses) • Contraindications: bleeding, thrombocytopenia, severe liver disease

  9. HEPARIN (continued) • Adverse Effects: bleeding, anemia, pain at injection site • Route: IV or subcutaneous; administer in abdominal tissue • Dosage: 5,000 units q 8-12 hr. (subcut) • Nursing Implications: • Assess for S/S bleeding (gums, nose, bruising, black stools, hematuria)

  10. HEPARIN (continued) • Assess injection site for hematoma, ecchymosis • Monitor PTT, Hg, Hct, Platelets **Antidote = Protamine Sulfate Refer to Davis Drug Guide for Nurses

  11. Heparin • Absorption: Quickly absorbed after injection • Distribution: Does not cross placenta or enter breast milk, Highly bound to proteins • Metabolism: probably metabolized by lymph system and spleen, unknown • Excretion: removed by lymph system and spleen • ½ life: 1-2 hour, dependent upon dosage • Onset: 20-60 min. • Peak: 2 hrs • Duration: 8-12 hrs.

  12. Medication Pass Preparation • Warfarin (Coumadin) • Classification: Anticoagulant • Indication: Prevention and treatment of venous thrombosis, PE, DVT, atrial fibrillation, MI • Common SE: Bleeding, nausea, fever • Route: *Oral, IV • Dosage: Oral – 2.5 – 10mg daily

  13. Medication Pass Preparation • Nursing Interventions: • Assess for signs of bleeding • Monitor PT/INR, CBC • Patients >60 may have greater than expected INR • High Alert medication • 3-5 days to reach effective levels • Instruct pt. to take med. at same time, evening • Avoid foods high in Vitamin K • Avoid Aspirin containing products and alcohol

  14. Medication Pass Preparation • MEDICATION NAME • (Generic, Trade Names) • CLASSIFICATION • ROUTE OF ADMINISTRATION • DOSAGE • INDICATION/THERAPEUTIC • USE • COMMON SIDE EFFECTS (LIST 3-4) • NURSING INTERVENTIONS

  15. Insulin • Humalog • Novolog • Humulin R • Novolin R • NPH • Lantus, Levimir

  16. INSULIN • Humalog • Cheaper ? • Novolog • Stronger ? • Humulin • Novolin • Rapid acting • Humalog, Novolog • Short acting • Humulin R, Novolin R • Intermediate acting • NPH • Long acting • Lantus, Levemir

  17. Insulin

  18. Insulin – refer to handout • Sliding Scale • Insulin Sensitivity Factor • Blood glucose minus target glucose (140) divided by ISF (40) • Carbohydrate Coverage • 1:10 • 1:15 • 1:20

  19. Insulin • Cheerios 20 gm. • 8 oz. skim milk 5 gm. • 2 slices toast 24 gm. • Butter 0 gm. • 4 oz. cranberry juice 6 gm. • Coffee 10 oz. 0 gm. • Splenda 0 gm.

More Related